Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$472K Buy
144,692
+11,183
+8% +$61K ﹤0.01% 3298
2026
Q1
$1.18M Buy
133,509
+960
+0.7% +$10K ﹤0.01% 2503
2025
Q4
$1.57M Sell
132,549
-64,688
-33% -$853K ﹤0.01% 2397
2025
Q3
$2.78M Buy
197,237
+45,049
+30% +$570K ﹤0.01% 2160
2025
Q2
$1.47M Sell
152,188
-29,284
-16% -$329K ﹤0.01% 2433
2025
Q1
$2.31M Buy
181,472
+11,603
+7% +$186K ﹤0.01% 2282
2024
Q4
$3.51M Sell
169,869
-62,783
-27% -$1.03M ﹤0.01% 2140
2024
Q3
$3.28M Sell
232,652
-13,573
-6% -$197K ﹤0.01% 2192
2024
Q2
$3.08M Buy
246,225
+10,720
+5% +$130K ﹤0.01% 2177
2024
Q1
$3.13M Sell
235,505
-1,422
-0.6% -$22K ﹤0.01% 2189
2023
Q4
$4.49M Buy
236,927
+13,672
+6% +$224K ﹤0.01% 2044
2023
Q3
$3.36M Buy
223,255
+1,615
+0.7% +$30.3K ﹤0.01% 2060
2023
Q2
$4.79M Buy
221,640
+16,754
+8% +$457K ﹤0.01% 1941
2023
Q1
$5.76M Sell
204,886
-22,735
-10% -$645K ﹤0.01% 1810
2022
Q4
$5.76M Buy
227,621
+45,133
+25% +$1.38M ﹤0.01% 1830
2022
Q3
$5.25M Buy
182,488
+9,447
+5% +$280K ﹤0.01% 1875
2022
Q2
$4.38M Buy
+173,041
New +$4.99M ﹤0.01% 2033

Other funds holding EMBC

Nuveen's EMBC Position: Q2 2026 in Review

Nuveen increased its Embecta (EMBC) stake by 8.4% in Q2 2026, buying an estimated $61K and bringing the position to 144,692 shares worth $472K. The position accounts for ﹤0.01% of the portfolio, ranked #3298.

Nuveen first reported a position in EMBC in Q2 2022 and has held it in 17 quarters since. The position peaked at $5.76M in Q1 2023. 320 funds tracked by Wall St. Rank hold EMBC as of Q2 2026.

  • Nuveen held 144,692 shares of Embecta worth $472K as of Q2 2026.
  • Nuveen bought 11,183 Embecta shares in Q2 2026, an estimated $61K.
  • Embecta made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3298 holding.
  • Nuveen first reported a position in Embecta in Q2 2022 and has held it in 17 quarters since.
  • Nuveen's Embecta position peaked at $5.76M in Q1 2023.
  • 320 funds tracked by Wall St. Rank held Embecta as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.